Microbubble contrast agents: a new era in ultrasound

Contrast agents are widely used in imaging, but until recently they had little place in ultrasonography. This has changed with the introduction of microbubbles—small (typically 3 μm in diameter) gas filled bubbles that are usually injected intravenously. Injecting a gas into the circulation may seem potentially hazardous, but extensive clinical experience has shown that the tiny volume of air or gas given (under 200 μl) is not dangerous, and the safety of microbubbles compares well to that of conventional agents in radiography and magnetic resonance imaging.1 Although microbubbles were originally designed simply to improve conventional ultrasound scanning, recent discoveries have opened up powerful emerging applications. This article describes some of these applications in radiology and cardiology and discusses the potential of microbubbles for therapy. We prepared this review from contributions from researchers with special knowledge of the use of microbubbles in radiology, cardiology, and treatment. We combined our personal experience in research over several years with a review of recent literature on the subject. Microbubbles work by resonating in an ultrasound beam, rapidly contracting and expanding in response to the pressure changes of the sound wave. By a fortunate coincidence, they vibrate particularly strongly at the high frequencies used for diagnostic ultrasound imaging. This makes them several thousand times more reflective than normal body tissues. In this way they enhance both grey scale images and flow mediated Doppler signals. As well as being useful in itself, the resonance that microbubbles produce has several special properties that can be exploited to improve diagnoses. Just as with a musical instrument, multiple harmonic signals—or overtones—are produced. Ultrasound scanners can be tuned to “listen” to these harmonics, producing strong preferential imaging of the microbubbles in an image. The selective excitation produced can also destroy microbubbles relatively easily, an effect that can be useful …

[1]  B. Choi,et al.  Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. , 2000, Radiology.

[2]  R V Shohet,et al.  Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. , 2000, Circulation.

[3]  Morton W. Miller,et al.  Gene transfection and drug delivery. , 2000, Ultrasound in medicine & biology.

[4]  H. Dittrich,et al.  Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material. , 2000, American heart journal.

[5]  J G Miller,et al.  Contrast Echocardiography: Current and Future Applications , 2000 .

[6]  D. Cosgrove,et al.  Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases , 2000, The Lancet.

[7]  D O Cosgrove,et al.  Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. , 1999, Ultrasound in medicine & biology.

[8]  T. Bourne,et al.  The assessment of endometrial pathology and tubal patency: a comparison between the use of ultrasonography and X‐ray hysterosalpingography for the investigation of infertility patients , 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  K Moehring,et al.  Reflux in young patients: comparison of voiding US of the bladder and retrovesical space with echo enhancement versus voiding cystourethrography for diagnosis. , 1999, Radiology.

[10]  Thomas Albrecht,et al.  Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent , 1999, The Lancet.

[11]  D O Cosgrove,et al.  Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. , 1999, Radiology.

[12]  P. Steg,et al.  Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: relation to timing and extent of functional recovery , 1999, Heart.

[13]  B. Goldberg,et al.  Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. , 1999, Radiology.

[14]  S. Taylor-Robinson,et al.  Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. , 1998, Radiology.

[15]  Y Wu,et al.  Binding and lysing of blood clots using MRX-408. , 1998, Investigative radiology.

[16]  T C Skalak,et al.  Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. , 1998, Circulation.

[17]  D S Segar,et al.  Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. , 1998, Journal of the American College of Cardiology.

[18]  S. Feinstein,et al.  Contrast echocardiography: review and future directions. , 1998, The American journal of cardiology.

[19]  D O Cosgrove,et al.  Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience. , 1998, Radiology.

[20]  J. Ruskin,et al.  Nonpharmacologic therapies for atrial fibrillation. , 1998, The American journal of cardiology.

[21]  J. Butler,et al.  Frequency of low-risk hospital admissions for heart failure. , 1998, The American journal of cardiology.

[22]  S. Russell,et al.  Science, medicine, and the future : Gene therapy , 1997, BMJ.

[23]  Edwin L. Carstensen,et al.  Echo-enhancing agents: safety , 1997 .

[24]  P. Iversen,et al.  Interaction of diagnostic ultrasound with synthetic oligonucleotide‐labeled perfluorocarbon‐exposed sonicated dextrose albumin microbubbles. , 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[25]  D. Cosgrove Why do we need contrast agents for ultrasound? , 1996, Clinical radiology.

[26]  R. Nakielny,et al.  Temporomandibular joint imaging. , 1996, Clinical radiology.

[27]  R. Schlief,et al.  A Transpulmonary Contrast Medium Enhances the Transcranial Doppler Signal in Humans , 1993, Stroke.

[28]  R. Apfel,et al.  Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. , 1991, Ultrasound in medicine & biology.